Bulletin
Investor Alert

Annovis Bio Inc.

NYS: ANVS

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Feb 3, 2023, 7:22 p.m.

/zigman2/quotes/216213707/composite

$

19.44

Change

+0.10 +0.52%

Volume

Volume 39

Quotes are delayed by 20 min

/zigman2/quotes/216213707/composite

Previous close

$ 19.33

$ 19.34

Change

+0.01 +0.05%

Day low

Day high

$18.50

$20.99

Open

52 week low

52 week high

$8.39

$23.91

Open

Mark White

Mark White is on the board of Annovis Bio, Inc.

He previously was Chief Executive Officer at Neurokine Therapeutics LLC, Senior Director & Group Leader-Pain Therapeutics at Pfizer Inc. and Senior Director-Marketing & Business Development at Bracco Diagnostics, Inc.

Mark White received an undergraduate degree and a graduate degree from the University of Missouri and an MBA from The University of Chicago Booth School of Business.

Transactions

Date Shares Transaction Value
10/12/2021 5,000   Acquisition at $27.4 per share. 137,000
01/31/2020 3,252   Derivative/Non-derivative trans. at $4.8 per share. 15,609
01/31/2020 34,643   Derivative/Non-derivative trans. at $0 per share. 0
01/31/2020 11,548   Derivative/Non-derivative trans. at $0 per share. 0
01/31/2020 1,734   Acquisition at $6 per share. 10,404

Officers and Executives

Dr. Maria-Luisa Maccecchini
President, Chief Executive Officer & Director
Mr. Henry Hagopian
Dr. Cheng Fang
Senior Vice President-Research & Development
Ms. Eve M. Damiano
Senior Vice President-Regulatory Operations
Mr. Michael B. Hoffman
Chairman
Mr. Reid S. McCarthy
Independent Director
Dr. Claudine E. Bruck
Independent Director
Mr. Mark White
Independent Director
Link to MarketWatch's Slice.